What's New in Health Care Reform: Feb. 6 - Insights
Top highlights include: New U.S. experiments aim to create gene-edited human embryos, death-cap mushrooms are spreading across North America, daily exercise has been shown to lower blood pressure, scans show female brains remain youthful as...
Phage immunoprecipitation sequencing identifies previously unknown disease biomarkers - Insights
In Mayo Clinic’s Advanced Diagnostics Laboratory, there are dozens of projects underway at once to develop new technologies, discover novel findings, validate new tests, and support physicians in providing advanced patient care. For...
New tests launched in August - Insights
In August 2022, Mayo Clinic Laboratories announced thirty-two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
One of the biggest misunderstandings about genetic testing is a perception that once a variant is identified and analyzed thoroughly, using all the best tools available, it can be associated with a specific disease or condition. But many...
Avoid seller's remorse: Why owning your lab makes sense - Insights
For community health care providers, owning a laboratory has been likened to shoveling money down a giant drain. Cayuga Medical Center is challenging that narrative. Instead of selling, Cayuga is investing in its lab — which it considers a...
Yuma Regional Medical Center: Changing perceptions and powering growth - Insights
Looking to elevate laboratory operations, Yuma Regional’s hospital directors established a leadership model that pairs medical and administrative leaders, resulting in a changed perception of the laboratory’s ability to drive profitability...
Sarcoma Informative Cases - Insights
Case #1 Case #2 Case #3 Case #4 Case #5 Sarcomas are malignant tumors that arise in the bone and soft tissue. With numerous subtypes of sarcoma that can
What's New in Health Care Reform: Jan. 23 - Insights
Top highlights include: Physician burnout now essentially a public health crisis, Americans more likely to die from opioid overdose than in a car accident, study identifies biomarkers to stratify patients for prostate cancer treatment, the...
BioPharma Diagnostics - Insights
BioPharma Diagnostics bring Mayo Clinic quality and expertise to collaborative engagements with biopharma, diagnostic and biotech companies to support a range of services, including clinical trial development, assay development, research...
UofL Health – UofL Hospital physicians and laboratory scientists faced challenges in the ordering of autoimmune and paraneoplastic panels: duplicate orders that add unnecessary cost and omitted test orders that could provide the key to the...
Then and now: Upholding Mayo Clinic's core values - Insights
Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.
MSA Patient Holds Steady Following Small Group Study of Stem Cell Therapy - Insights
Steve Day experiences balance issues, sleeping problems, and irregular blood pressure stem from a rare, unusual neurodegenerative disease—multiple system atrophy. Read his story.
Amid COVID-19 upheaval, DLMP staff steps up - Insights
When COVID-19 hit, staff in Laboratory Medicine and Pathology at Mayo Clinic rose to the challenge with perseverance, flexibility, and resilience.
Ingenuity, collaboration, and expertise create a game-changing COVID-19 test swab - Insights
A massive effort culminated in Mayo Clinic designing, testing and mass-manufacturing a 3D-printed mid-turbinate swab for COVID-19 testing.
A novel testing approach for newly identified VEXAS syndrome - Insights
VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. The underlying cause of newly identified VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome —...
Prostate Health Index (phi) [A Test in Focus] (Spanish) - Insights
https://www.youtube.com/watch?v=D5Q12Fk-J2Q
Hurricane Hilary: Potential specimen delays - Insights
Hurricane Hilary will be impacting the West Coast this weekend and into early next week. We are monitoring and tracking the situation with our logistics partners to minimize challenges. Clients will be contacted directly by the couriers if...
Ann Moyer, M.D., Ph.D., discusses an additional gene, NUDT15, which is important in the prediction of thiopurine-related toxicity This gene has been added to our TPMT genotyping assay available through Mayo Medical Laboratories.
It's Tick Season: Bobbi Pritt, M.D., Featured on Mayo Clinic Radio - Insights
On the June 2 broadcast of Mayo Clinic Radio, co-hosts Tracy McCray and Tom Shives, M.D., spoke with Bobbi Pritt, M.D., Director of the Mayo Clinic Clinical Parasitology Lab, about common tick-borne diseases and how to prevent them.
We want to express our gratitude for what laboratory professionals do each and every day. As we celebrate Lab Week this year, we recognize more than ever that the laboratory is the backbone of the hospital. Together we will continue to make...
Specimen Shipment Alert: Jan. 30 - Insights
In close collaboration with our logistics providers, we have determined that clients can now safely send all specimens to Rochester now that temperatures have moderated. Thank you for your patience and understanding.
Thank you to all our staff during the time of COVID-19 - Insights
Thank you to our staff at Mayo Clinic who step up daily during this time of need to provide access to testing during the global pandemic. We appreciate each one of you and all the sacrifices you personally have made throughout this past...
Monitoring winter storms - Insights
Mayo Clinic Laboratories is monitoring and tracking back-to-back winter storms moving through the Midwest and East Coast to minimize challenges. Engagement with our logistics partners is underway to minimize challenges. If any routes are...
Hurricane Lee: Potential specimen delays - Insights
Hurricane Lee will be impacting the New England area and northeastern Canada this weekend. We are monitoring and tracking the situation with our logistics partners to minimize challenges. Your organization will be contacted directly by the...
Mayo Clinic monitoring rising avian influenza cases - Insights
In a post on Mayo Clinic’s News Network, Mayo Clinic’s director of Clinical Virology, Matthew Binnicker, Ph.D., explains the concern over a potential human-to-human outbreak of avian influenza and what’s being done at Mayo Clinic and...
Thank you for your collaboration in 2023 - Insights
Mayo Clinic Laboratories is grateful for the opportunity to serve you and other healthcare professionals around the globe in providing critical answers and actionable insights.
Monitoring Hurricane Debby - Insights
As Hurricane Debby moves through the Southeast United States (Florida, Georgia, South Carolina, North Carolina, and Virginia), we continue to monitor and track the situation with our logistics partners to minimize challenges. Clients in the...
Gratitude for your collaboration in 2024 - Insights
Mayo Clinic Laboratories is grateful for your collaboration in 2024.
Regaining quality of life after a decade lost to misdiagnosis: Kelly Dubois - Insights
Misdiagnosed with acromegaly, a disease marked by too much growth hormone, and plagued by a host of mysterious health problems from unnecessary medications, Kelly DuBois finally found answers after pharmacogenomic testing from Mayo Clinic...
Sorting through the Details of an Automation Solution - Insights
Laboratories face increasing pressure to automate their operations as they are challenged by a continuing increase in workload, a need to reduce expenditure, and a demand for accuracy and improved turnaround time—essentially doing more with...
Dr. Robin Patel shares periprosthetic joint infection findings in NEJM - Insights
The New England Journal of Medicine recently published new findings on periprosthetic joint infection by Dr. Robin Patel.
Mayo Clinic Laboratories named by HHS to expand monkeypox testing capacity - Insights
The Department of Health and Human Services has named Mayo Clinic Laboratories as one of five commercial laboratories to expand access and capacity for monkeypox testing.
Hurricane Ian update - Insights
Due to hurricane Ian, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.
COVID-19 weekly news: May 2-8 2022 - Insights
Topics include: Hepatitis in children: What parents need to know, and FDA limits use of J&J COVID-19 vaccine.
Mayo Clinic develops and validates new antibody test to diagnose multiple sclerosis - Insights
Mayo Clinic researchers have developed and validated a new antibody test to diagnose multiple sclerosis (MS). The new test is an automated and cost-effective method compared to other tests used to diagnose MS, according to the research...
As Winter Storm Blair moves through the Midwest and East Coast, Mayo Clinic Laboratories will monitor and track the situation with our logistics partners to minimize challenges. If any routes are modified or canceled, clients in the...
Testing for COVID-19: Which test to use when? - Insights
If you need a test for COVID-19, a variety of options are now available. But how do you know which one is right for you? Use this guide from Mayo Clinic Laboratories to sort through the choices and help you decide.
Mayo Clinic neuropathologist Caterina Giannini, M.D., Ph.D., received the American Association of Neuropathologists’ (AANP) award for Meritorious Contributions to Neuropathology during the AANP’s 98th annual meeting in June.
Mayo Clinic Laboratories offers an innovative testing solution for the early detection of Alzheimer's disease. Learn more at the AAIC 2022 tradeshow.
Elitza Theel, Ph.D., Featured in the Star Tribune - Insights
Dr. Theel, director, Mayo Clinic Infectious Diseases Serology Laboratory, was recently highlighted in the Star Tribune's special issue featuring heroes of the pandemic.
Together, Mayo Clinic Laboratories and Helix will provide biopharma customers with a full spectrum of testing capabilities and end-to-end laboratory testing support.
CPT Codes and LOINC Update: February 2020 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of February 2020.
Clinical Chemistry Textbook Features Mayo Contributors - Insights
There are more Mayo Clinic contributors in the sixth edition of the "Tietz Textbook of Clinical Chemistry and Molecular Diagnostics" than from any other institution—a noteworthy accomplishment.
Laboratory Finance: Make Every Dollar Work for You - Insights
Interested in understanding laboratory finance and how to make every dollar work for you? Jane Hermansen, Manager of Outreach and Network Development at Mayo Clinic Laboratories, provides insight on how to define revenue streams, clearly...
Jeff Meeusen, Ph.D., Published in ATVB - Insights
Jeff Meeusen, Ph.D., Co-Director of Cardiovascular Laboratory Medicine, recently had his paper, “Plasma Ceramides—A Novel Predictor of Major Adverse Cardiovascular Events after Coronary Angiography” accepted by the peer-reviewed journal...
News conference focuses on Mayo Clinic front-line workers - Insights
Aimee Boerger, who works at Mayo Clinic Laboratories, was among the staff members who shared their stories.
Medical Laboratory Science Program Celebrates 2017 Graduating Class - Insights
The Mayo Clinic School of Health Sciences Medical Laboratory Science Program celebrated the 2017 graduating class during a ceremony on May 25. Of the 24 graduates, 18 accepted positions within the Department of Laboratory Medicine and...
G2 Special Report: The Counter-Argument to Selling Your Hospital Lab - Insights
In collaboration with G2 Intelligence and author Jeff Downs, Mayo Medical Laboratories has secured the rights for our clients to download, the G2 Special Report: "The Counter-Argument to Selling Your Hospital Lab."
COVID-19 weekly news: March 14-20 2022 - Insights
Topic's Include: Mayo Clinic Q&A podcast: COVID-19 update, and Mayo Clinic Minute: Hope for COVID-19 patients who’ve lost their sense of taste, smell.
New tests launched in July - Insights
In July 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.